Rising Cancer Prevalence Propels Growth In The Single-Cell Omics Market: An Emerging Driver Transforming The Single-Cell Omics Market Landscape

The Single-Cell Omics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Projected Growth of the Single-Cell Omics Market?
In recent times, there has been a significant expansion in the size of the single-cell omics market. It is predicted to increase from $2.08 billion in 2024 to $2.41 billion in 2025, indicating a Compound Annual Growth Rate (CAGR) of 15.9%. The rise observed over the previous years can be associated with factors like the discovery of cellular heterogeneity, the development of single-cell analysis instruments, advancements in biomedical research, characterization of the immune system, and increasing focus on precision medicine.

The market size of single-cell omics is anticipated to experience swift enlargement in the forthcoming years, with expectations of reaching $4.52 billion by 2029, with a compound annual growth rate (CAGR) of 17.0%. Elements contributing to the growth during this forecast period include diagnostic and clinical adoption, integration with multi-omics strategies, application in cellular therapies, drug discovery, and regenerative medicine, and immunotherapies. Key trends projected within the forecast time frame encompass in vivo single-cell studies, single-cell omics application in the research of infectious diseases, microfluidics integration with single-cell sorting, single-cell multi-omics amalgamation, and spatial single-cell analysis.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12379

What Are the Different Single-Cell Omics Market Segments?
The single-cell omics market covered in this report is segmented -

1) By Product: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, Single-Cell Metabolomics
2) By Technology: Cell Isolation Technologies, Sample Preparation Technologies, Analysis Of Next-Generation Sequencing
3) By Application: Oncology, Cell Biology, Neurology, Immunology
4) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Organizations, Hospital And Diagnostic Laboratories, Other End Users

Subsegments:
1) By Single-Cell Genomics: Whole Genome Sequencing (WGS), Targeted Sequencing, Single-Cell DNA Analysis Kits
2) By Single-Cell Transcriptomics: RNA Sequencing (RNA-seq), Quantitative PCR (qPCR) For Single Cells, Single-Cell Gene Expression Analysis Kits
3) By Single-Cell Proteomics: Mass Spectrometry-Based Proteomics, Antibody-Based Protein Analysis, Single-Cell Protein Analysis Kits
4) By Single-Cell Metabolomics: Mass Spectrometry For Metabolites, Nuclear Magnetic Resonance (NMR) Metabolomics, Single-Cell Metabolite Profiling Kits

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12379&type=smp

What Are the Primary Drivers Shaping the Single-Cell Omics Market?
The surge in cancer cases is anticipated to fuel the expansion of the single-cell omics market. Cancer encompasses a variety of diseases that can emerge in nearly any organ or tissue in the body as abnormal cells multiply uncontrollably, exceed their typical boundaries, and either proliferate to other organs or infiltrate surrounding body tissues. Single-cell omics data have significantly contributed to the identification of cancer biomarkers for diagnosis, forecasting outcomes, and unearthing new therapeutic targets within established clinical cohorts. For example, the National Institutes of Health, a government agency in the US, reported in May 2024 that around 18.1 million people in the US were living with cancer as of January 2022. This figure is projected to reach 22.5 million by 2032. Therefore, the escalating incidence of cancer is facilitating the growth of the single-cell omics market.

Which Companies Are Leading in the Single-Cell Omics Market?
Major companies operating in the single-cell omics market include Danaher Corporation, Merck KGaA, Becton Dickinson and Company, GE HealthCare Technologies Inc., Thermo Fischer Scientific Inc., Agilent Technologies Inc., Sartorius AG, Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V, DiaSorin S.p.A., Tecan Group Ltd., BGI Genomics Co. Ltd., Promega Corporation, 10x Genomics Inc., Takara Bio Inc., NanoString Technologies Inc., Vizgen, HiFiBiO Therapeutics, Deepcell, Immunai, Mission Bio Inc., Standard BioTools Inc., CYTENA GmbH, Celsius Therapeutics, Scailyte AG, Single Cell Discoveries, ImmunoScape Pte. Ltd., Nodexus Inc., 1CellBio Inc.

What Are the Major Trends Shaping the Single-Cell Omics Market?
The emergence of product innovation is an increasing trend in the single-cell omics market. Large corporations involved in the single-cell omics market are creating novel products to maintain their market standing. For example, in May 2023, Deepcell, a company based in the US that delivers software for single-cell dimensional morphology analysis, introduced the REM-I Platform. This scalable single-cell imaging facilitates high-dimensional analysis and cell sorting, offering unprecedented insights into cell biology. The REM-I Platform will open novel avenues for discovery in diverse areas like cancer biology, developmental biology, stem cell biology, gene therapy, and functional screening, due to its integration of single-cell imaging, sorting, and high-dimensional analysis.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/single-cell-omics-global-market-report

What Are the Top Revenue-Generating Geographies in the Single-Cell Omics Market?
North America was the largest region in the single-cell omics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell omics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Single-Cell Omics Market?
2. What is the CAGR expected in the Single-Cell Omics Market?
3. What Are the Key Innovations Transforming the Single-Cell Omics Industry?
4. Which Region Is Leading the Single-Cell Omics Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.